Boothbay Fund Management’s Coherus Oncology CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.8K	Sell	15,287 -4,001	-21%	-$7.11K	﹤0.01%	1955
2025 Q4	$27.4K	Hold	19,288	–	–	﹤0.01%	1866
2025 Q3	$31.6K	Buy	19,288 +5,910	+44%	+$6.57K	﹤0.01%	1807
2025 Q2	$9.78K	Hold	13,378	–	–	﹤0.01%	1405
2025 Q1	$10.8K	Hold	13,378	–	–	﹤0.01%	1348
2024 Q4	$18.5K	Sell	13,378 -6,840	-34%	-$7.67K	﹤0.01%	1421
2024 Q3	$21K	Hold	20,218	–	–	﹤0.01%	1547
2024 Q2	$35K	Sell	20,218 -1,046	-5%	-$2.1K	﹤0.01%	1433
2024 Q1	$50.8K	Sell	21,264 -79,880	-79%	-$197K	﹤0.01%	1468
2023 Q4	$337K	Sell	101,144 -96,222	-49%	-$258K	0.01%	1143
2023 Q3	$738K	Buy	197,366 +182,366	+1,216%	+$842K	0.02%	892
2023 Q2	$64K	Buy	+15,000	New	+$88.5K	﹤0.01%	1664
2020 Q1	–	Sell	-12,000	Closed	-$222K	–	873
2019 Q4	$216K	Sell	12,000 -20,747	-63%	-$383K	0.02%	690
2019 Q3	$663K	Sell	32,747 -1,678	-5%	-$33.5K	0.06%	401
2019 Q2	$761K	Buy	+34,425	New	+$598K	0.07%	332